AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glyoka-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Ayati Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glyoka-M1 Tablet PR

Diabexe Duo tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are critical in diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, lightheadedness, headache, and trembling—and appropriate countermeasures. Regular meals and readily accessible fast-acting glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (blood counts and liver function) are recommended.

Uses of Glyoka-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glyoka-M1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Glyoka-M1 Tablet PR should be ingested with a meal.

Common Side effects of Glyoka-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyoka-M1 Tablet PR:

Follow your physician's instructions or refer to the product label for proper administration. Ingest Glyoka-M1 Tablet PR with a meal.

How Glyoka-M1 Tablet PR works:

Glyoka-M1 PR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glyoka-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyoka-M1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Glyoka-M1 Tablet PR is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glyoka-M1 Tablet PR, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glyoka-M1 Tablet PR. Physician consultation is recommended. Regular monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyoka-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically advised for those with mild to moderate liver disease; Glyoka-M1 Tablet PR is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glyoka-M1 Tablet PR :

Should you forget a Glyoka-M1 Tablet PR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyoka-M1 Tablet PR

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Glyoka-M1 Tablet PR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glyoka-M1 Tablet PR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, or bradycardia warrant immediate discontinuation of Glyoka-M1 Tablet PR and prompt medical attention.
Glyoka-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise regimen. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases liver glucose production and enhances insulin effectiveness. This combination is unsuitable for type 1 diabetes.
Glyoka-M1 Tablet PR may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially severe side effects such as lactic acidosis have also been reported. Prolonged administration may result in vitamin B12 depletion.
Prolonged Glyoka-M1 Tablet PR administration can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some studies involve annual supplemental Vitamin B12 intake.
Indeed, Glyoka-M1 Tablet PR can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition may include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glyoka-M1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use with this medication also raises the likelihood of lactic acidosis.
Glyoka-M1 Tablet PR
45
MRP 55
18% off